SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+4.59%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$624M
AUM Growth
+$624M
(+12%)
Cap. Flow
+$64.2M
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
33.26%
Holding
155
New
31
Increased
26
Reduced
30
Closed
22
Top Buys
| 1 |
Viatris
VTRS
|
$32M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$14.4M |
| 3 |
Amicus Therapeutics
FOLD
|
$9.79M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.74M |
| 5 |
Viking Therapeutics
VKTX
|
$7.53M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$18.6M |
| 2 |
Biogen
BIIB
|
$9.81M |
| 3 |
Ituran Location and Control
ITRN
|
$8.27M |
| 4 |
ORBK
Orbotech Ltd
ORBK
|
$6.62M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$5.33M |
Sector Composition
| 1 | Healthcare | 80.48% |
| 2 | Technology | 4.94% |
| 3 | Communication Services | 3.07% |
| 4 | Financials | 1.38% |
| 5 | Consumer Discretionary | 1.28% |
